Variant report

Variant	esv3519628
Chromosome Location	chr7:100320350-100343994
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr7:100342820-100343137	H1-hESC	embryonic stem cell:	n/a	chr7:100343059-100343070
2	ATF3	chr7:100342893-100343212	K562	blood:	n/a	chr7:100343059-100343070
3	ATF3	chr7:100342909-100343195	H1-hESC	embryonic stem cell:	n/a	chr7:100343059-100343070
4	BACH1	chr7:100342894-100343159	H1-hESC	embryonic stem cell:	n/a	n/a
5	BHLHE40	chr7:100342972-100343060	K562	blood:	n/a	n/a
6	BHLHE40	chr7:100323056-100323064	K562	blood:	n/a	n/a
7	BHLHE40	chr7:100325083-100325234	HepG2	liver:	n/a	n/a
8	BHLHE40	chr7:100322927-100323222	GM12878	blood:	n/a	n/a
9	BRCA1	chr7:100322901-100323144	Hela-S3	cervix:	n/a	n/a
10	BRCA1	chr7:100323452-100323651	Hela-S3	cervix:	n/a	n/a
11	BRCA1	chr7:100323502-100323569	H1-hESC	embryonic stem cell:	n/a	n/a
12	CBX3	chr7:100342793-100343201	K562	blood:	n/a	n/a
13	CCNT2	chr7:100322941-100323060	K562	blood:	n/a	n/a
14	CEBPB	chr7:100343705-100343937	K562	blood:	n/a	n/a
15	CEBPB	chr7:100342881-100343252	IMR90	lung:	n/a	chr7:100343086-100343094
16	CEBPB	chr7:100342877-100343235	H1-hESC	embryonic stem cell:	n/a	chr7:100343086-100343094
17	CEBPB	chr7:100322878-100323040	K562	blood:	n/a	chr7:100322907-100322918 chr7:100322906-100322923 chr7:100322908-100322919 chr7:100322907-100322920
18	CEBPB	chr7:100323378-100323661	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr7:100328044-100328375	HepG2	liver:	n/a	chr7:100328193-100328204
20	CEBPB	chr7:100323349-100323710	IMR90	lung:	n/a	n/a
21	CEBPB	chr7:100342882-100343246	K562	blood:	n/a	chr7:100343086-100343094
22	CEBPB	chr7:100322905-100323161	Hela-S3	cervix:	n/a	chr7:100322907-100322918 chr7:100322906-100322923 chr7:100322908-100322919 chr7:100322907-100322920
23	CEBPB	chr7:100343609-100343978	MCF-7	breast:	n/a	n/a
24	CEBPB	chr7:100343788-100343966	HepG2	liver:	n/a	n/a
25	CEBPB	chr7:100322913-100322974	HepG2	liver:	n/a	n/a
26	CEBPB	chr7:100328137-100328308	Hela-S3	cervix:	n/a	chr7:100328193-100328204
27	CEBPB	chr7:100328048-100328277	K562	blood:	n/a	chr7:100328193-100328204
28	CEBPB	chr7:100328040-100328372	HepG2	liver:	n/a	chr7:100328193-100328204
29	CEBPB	chr7:100324990-100325273	HepG2	liver:	n/a	n/a
30	CEBPB	chr7:100322881-100323134	H1-hESC	embryonic stem cell:	n/a	chr7:100322907-100322918 chr7:100322906-100322923 chr7:100322908-100322919 chr7:100322907-100322920
31	CEBPB	chr7:100342869-100343223	K562	blood:	n/a	chr7:100343086-100343094
32	CEBPB	chr7:100328099-100328290	IMR90	lung:	n/a	chr7:100328193-100328204
33	CEBPB	chr7:100343051-100343081	HepG2	liver:	n/a	n/a
34	CEBPB	chr7:100328148-100328292	A549	lung:	n/a	chr7:100328193-100328204
35	CEBPD	chr7:100328091-100328340	HepG2	liver:	n/a	n/a
36	CREB1	chr7:100342840-100343218	H1-hESC	embryonic stem cell:	n/a	n/a
37	CREB1	chr7:100342840-100343272	GM12878	blood:	n/a	n/a
38	CTCF	chr7:100322947-100323179	A549	lung:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
39	CTCF	chr7:100323020-100323170	HPF	lung:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
40	CTCF	chr7:100322781-100323243	H1-hESC	embryonic stem cell:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
41	CTCF	chr7:100323000-100323150	BE2_C	brain:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
42	CTCF	chr7:100323040-100323190	HMEC	breast:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
43	CTCF	chr7:100323020-100323170	GM12873	blood:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
44	CTCF	chr7:100323020-100323170	AG09309	skin:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
45	CTCF	chr7:100323360-100323510	GM12875	blood:	n/a	n/a
46	CTCF	chr7:100323300-100323450	HVMF	connective:	n/a	n/a
47	CTCF	chr7:100322702-100323888	SK-N-SH	brain:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
48	CTCF	chr7:100323040-100323190	BJ	skin:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
49	CTCF	chr7:100322978-100323187	GM20000	blood:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094
50	CTCF	chr7:100323020-100323170	HA-sp	spinal cord:	n/a	chr7:100323077-100323093 chr7:100323071-100323092 chr7:100323076-100323094

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:100330109-100330159	K562	blood:	n/a
2	chr7:100330109-100330159	AG09309	skin:	n/a
3	chr7:100321217-100321267	AG09309	skin:	n/a
4	chr7:100343110-100343160	HRPEpiC	eye:	n/a
5	chr7:100324222-100324272	H1-hESC	embryonic stem cell:	embryo
6	chr7:100343110-100343160	NB4	blood:	n/a
7	chr7:100324222-100324272	Jurkat	blood:	n/a
8	chr7:100324222-100324272	HL-60	blood:	n/a
9	chr7:100330109-100330159	SAEC	small airway:	n/a
10	chr7:100321217-100321267	NB4	blood:	n/a
11	chr7:100330872-100330922	MCF-7	breast:	n/a
12	chr7:100330872-100330922	PrEC	prostate:	n/a
13	chr7:100330872-100330922	T-47D	breast:	n/a
14	chr7:100324222-100324272	HRCEpiC	kidney:	n/a
15	chr7:100324222-100324272	K562	blood:	n/a
16	chr7:100343110-100343160	CMK	blood:	n/a
17	chr7:100343083-100343133	HL-60	blood:	n/a
18	chr7:100321217-100321267	ECC-1	luminal epithelium:	n/a
19	chr7:100324222-100324272	Hela-S3	cervix:	n/a
20	chr7:100321217-100321267	MCF10A-Er-Src	breast:	n/a
21	chr7:100330872-100330922	NHDF-neo	bronchial:	n/a
22	chr7:100330109-100330159	Hepatocyte	liver:	n/a
23	chr7:100330109-100330159	HAEpiC	amniotic membrane:	n/a
24	chr7:100330587-100330637	RPTEC	kidney:	n/a
25	chr7:100330872-100330922	GM12892	blood:	n/a
26	chr7:100343110-100343160	SK-N-SH_RA	brain:	n/a
27	chr7:100330587-100330637	HMEC	breast:	n/a
28	chr7:100343110-100343160	HAEpiC	amniotic membrane:	n/a
29	chr7:100324222-100324272	A549	lung:	n/a
30	chr7:100321217-100321267	SK-N-SH_RA	brain:	n/a
31	chr7:100321217-100321267	HEK293	kidney:	embryo
32	chr7:100330109-100330159	ProgFib	skin:	n/a
33	chr7:100330872-100330922	HRCEpiC	kidney:	n/a
34	chr7:100321217-100321267	HL-60	blood:	n/a
35	chr7:100321217-100321267	GM12878	blood:	n/a
36	chr7:100330109-100330159	HL-60	blood:	n/a
37	chr7:100330109-100330159	Jurkat	blood:	n/a
38	chr7:100330587-100330637	HRE	kidney:	n/a
39	chr7:100343083-100343133	NB4	blood:	n/a
40	chr7:100330872-100330922	PFSK-1	brain:	n/a
41	chr7:100324222-100324272	U87	brain:	n/a
42	chr7:100343110-100343160	T-47D	breast:	n/a
43	chr7:100330109-100330159	HIPEpiC	eye:	n/a
44	chr7:100330109-100330159	U87	brain:	n/a
45	chr7:100343083-100343133	PFSK-1	brain:	n/a
46	chr7:100324222-100324272	GM12878	blood:	n/a
47	chr7:100330872-100330922	HCPEpiC	choroid plexus:	n/a
48	chr7:100330872-100330922	ProgFib	skin:	n/a
49	chr7:100330587-100330637	SK-N-MC	brain:	n/a
50	chr7:100343110-100343160	A549	lung:	n/a

No.	Distal block	Cell Line	Cell type
1	chr7:100288252..100292867-chr7:100319528..100322364,4	K562	blood:
2	chr7:100161316..100162153-chr7:100322612..100323132,2	K562	blood:
3	chr7:100317495..100321039-chr7:100423744..100425687,3	MCF-7	breast:
4	chr7:100315279..100318194-chr7:100320126..100322658,3	K562	blood:
5	chr7:100303316..100305278-chr7:100323603..100325231,2	K562	blood:
6	chr7:100074435..100077431-chr7:100322288..100324848,2	MCF-7	breast:
7	chr7:100336156..100338514-chr7:100343827..100346025,2	K562	blood:
8	chr7:100302051..100306591-chr7:100312993..100321692,11	MCF-7	breast:
9	chr7:100325203..100328007-chr7:100356386..100357913,2	K562	blood:
10	chr7:100302568..100303662-chr7:100322644..100323525,3	K562	blood:
11	chr7:100033824..100035649-chr7:100341389..100343074,2	K562	blood:
12	chr7:100314177..100318194-chr7:100318771..100321626,3	K562	blood:
13	chr7:100183516..100185859-chr7:100318860..100320461,2	MCF-7	breast:
14	chr7:100319576..100322114-chr7:100397770..100400557,3	MCF-7	breast:
15	chr7:100315257..100318069-chr7:100320272..100323098,2	MCF-7	breast:
16	chr7:100321531..100325332-chr7:100423998..100426364,3	MCF-7	breast:
17	chr7:100181969..100184766-chr7:100322000..100326304,4	MCF-7	breast:
18	chr7:100317007..100319008-chr7:100325168..100326733,2	K562	blood:
19	chr7:100302588..100303466-chr7:100322910..100323642,3	MCF-7	breast:
20	chr7:100291635..100293380-chr7:100321369..100322955,2	MCF-7	breast:
21	chr7:100161665..100162171-chr7:100322646..100323567,2	MCF-7	breast:
22	chr7:100324153..100326301-chr7:100361628..100364421,2	K562	blood:
23	chr7:100330076..100331647-chr7:100341645..100343390,2	K562	blood:
24	chr7:100326112..100327796-chr7:100392464..100395372,2	MCF-7	breast:
25	chr7:100302553..100308135-chr7:100314195..100322207,16	MCF-7	breast:
26	chr7:100336156..100338514-chr7:100343827..100346025,2	K562	blood:
27	chr7:100322778..100325308-chr7:100423819..100426319,3	MCF-7	breast:

Variant related genes	Relation type
ZAN	TF binding region
ZAN	CpG island
ENSG00000196411	chromatin interactions
ENSG00000130427	chromatin interactions
ENSG00000146839	chromatin interactions
ENSG00000166925	chromatin interactions
ENSG00000146828	chromatin interactions
ENSG00000160813	chromatin interactions
ENSG00000172336	chromatin interactions
ENSG00000106336	chromatin interactions
ENSG00000077454	chromatin interactions
ENSG00000240211	chromatin interactions

Extended variants
information (count: 859 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:859 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs569327723	chr7:100320376-100320377	Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs11976235	chr7:100320381-100320382	Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs551748179	chr7:100320399-100320400	Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs566780061	chr7:100320415-100320416	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs372093552	chr7:100320416-100320417	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs200241729	chr7:100320429-100320430	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs376551627	chr7:100320432-100320433	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs369003114	chr7:100320449-100320450	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs376745626	chr7:100320450-100320451	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs1126887	chr7:100320458-100320459	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs535223720	chr7:100320477-100320478	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs145666650	chr7:100320495-100320496	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs148112068	chr7:100320547-100320548	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs577308816	chr7:100320557-100320558	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs372954682	chr7:100320568-100320569	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs545543326	chr7:100320579-100320580	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs373508155	chr7:100320582-100320583	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs371645952	chr7:100320583-100320584	Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs201051019	chr7:100320604-100320605	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs149431976	chr7:100320614-100320615	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs375550656	chr7:100320618-100320619	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs370232752	chr7:100320626-100320627	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs78925197	chr7:100320627-100320628	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs373734290	chr7:100320641-100320642	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs201326665	chr7:100320661-100320662	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs73409075	chr7:100320670-100320671	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs144031260	chr7:100320726-100320727	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs368744075	chr7:100320733-100320734	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs530329727	chr7:100320750-100320751	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs371108812	chr7:100320751-100320752	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs375035296	chr7:100320761-100320762	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs189775061	chr7:100320786-100320787	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs563121954	chr7:100320787-100320788	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs200436414	chr7:100320802-100320803	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs202242218	chr7:100320819-100320820	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs551617369	chr7:100320825-100320826	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs141911577	chr7:100320849-100320850	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs192883541	chr7:100320862-100320863	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs150610526	chr7:100320899-100320900	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs184441242	chr7:100320935-100320936	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs535398997	chr7:100320976-100320977	Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs550360369	chr7:100321012-100321013	Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs78182250	chr7:100321023-100321024	Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs77450727	chr7:100321091-100321092	Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs188830852	chr7:100321107-100321108	Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs564449	chr7:100321138-100321139	Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs533509296	chr7:100321175-100321176	Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs564197288	chr7:100321176-100321177	Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs574378882	chr7:100321186-100321187	Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs114461287	chr7:100321218-100321219	Weak transcription Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Malignant melanoma	17260012	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Chronic myeloid leukemia	21384125	CNVD
Bladder cancer	21909424	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	16608533	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Liver carcinoma	19366792	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Adenocarcinoma	19607727	CNVD
Multiple myeloma	16461302	CNVD
Breast cancer	21858162	CNVD
Emphysema	19352772	CNVD
Effusion lymphoma	18079361	CNVD
Medulloblastoma	17653508	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Autism	19401682	CNVD
Neuroticism	17667963	CNVD
Breast cancer	21509527	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:275 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:100317800-100321000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
2	chr7:100318600-100320400	Flanking Active TSS	HepG2	liver
3	chr7:100319200-100342800	Weak transcription	Right Atrium	heart
4	chr7:100319400-100320400	Enhancers	Liver	Liver
5	chr7:100320000-100320400	Enhancers	Pancreas	Pancrea
6	chr7:100320000-100321400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
7	chr7:100320000-100322800	Weak transcription	Placenta	Placenta
8	chr7:100320200-100320400	Bivalent/Poised TSS	Spleen	Spleen
9	chr7:100320200-100322800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr7:100320400-100320600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr7:100320400-100320600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr7:100320400-100321400	Transcr. at gene 5' and 3'	HepG2	liver
13	chr7:100320400-100321800	Flanking Active TSS	Pancreas	Pancrea
14	chr7:100320400-100322200	Flanking Active TSS	Liver	Liver
15	chr7:100321400-100321600	Flanking Bivalent TSS/Enh	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr7:100321400-100321600	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr7:100321400-100321600	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr7:100321400-100321600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
19	chr7:100321400-100321600	Bivalent Enhancer	Fetal Stomach	stomach
20	chr7:100321400-100322000	Flanking Active TSS	HepG2	liver
21	chr7:100321800-100322000	Enhancers	Pancreas	Pancrea
22	chr7:100322000-100323200	Weak transcription	Pancreas	Pancrea
23	chr7:100322000-100326400	Enhancers	HepG2	liver
24	chr7:100322200-100325400	Enhancers	Liver	Liver
25	chr7:100322800-100323000	Enhancers	H9 Cell Line	embryonic stem cell
26	chr7:100322800-100323000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
27	chr7:100322800-100323000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr7:100322800-100323000	Flanking Active TSS	Primary B cells from cord blood	blood
29	chr7:100322800-100323000	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
30	chr7:100322800-100323000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
31	chr7:100322800-100323000	Flanking Active TSS	Brain Angular Gyrus	brain
32	chr7:100322800-100323000	Flanking Active TSS	Brain Germinal Matrix	brain
33	chr7:100322800-100323000	Flanking Bivalent TSS/Enh	Duodenum Smooth Muscle	Duodenum
34	chr7:100322800-100323000	Bivalent Enhancer	Fetal Brain Male	brain
35	chr7:100322800-100323000	Enhancers	Lung	lung
36	chr7:100322800-100323000	Flanking Active TSS	Dnd41	blood
37	chr7:100322800-100323200	Active TSS	iPS-15b Cell Line	embryonic stem cell
38	chr7:100322800-100323200	Enhancers	Primary B cells from peripheral blood	blood
39	chr7:100322800-100323200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
40	chr7:100322800-100323200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
41	chr7:100322800-100323200	Enhancers	Primary T regulatory cells fromperipheralblood	blood
42	chr7:100322800-100323200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr7:100322800-100323200	Bivalent Enhancer	Fetal Muscle Leg	muscle
44	chr7:100322800-100323200	Bivalent Enhancer	Fetal Stomach	stomach
45	chr7:100322800-100323400	Active TSS	ES-I3 Cell Line	embryonic stem cell
46	chr7:100322800-100323400	Active TSS	iPS-20b Cell Line	embryonic stem cell
47	chr7:100322800-100323400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
48	chr7:100322800-100323400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
49	chr7:100322800-100323400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
50	chr7:100322800-100323400	Enhancers	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links